ReviewCurrent psychiatry reports2009
Neuropsychological abnormalities in schizophrenia and major mood disorders: similarities and differences.
Review in Current psychiatry reports, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
49 citing papers in PubMed, 3 syntheses or guidelines pooled it, 86 citations in OpenAlex.
- Transdiagnostic mapping of brain structural abnormalities and network-constrained gray matter atrophy patterns across affective and psychotic disorders.Molecular psychiatry · 2026Pooled it
- Randomised controlled cognition trials in remitted patients with mood disorders published between 2015 and 2021: A systematic review by the International Society for Bipolar Disorders Targeting Cognition Task Force.Bipolar disorders · 2022Pooled it
- Neuropsychological performance in older patients with schizophrenia: a meta-analysis of cross-sectional and longitudinal studies.Schizophrenia bulletin · 2011Pooled it
- Trial
- Unique signatures in verbal fluency task performance in schizophrenia and depression.Schizophrenia research. Cognition · 2026Article
- Distinct cognitive trajectories in the early course of psychosis are associated with clinical and functional outcomes longitudinally.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2025Article
- Ecological validity in cognitive assessment and treatment.Schizophrenia research. Cognition · 2025Article
- Translating Molecular Psychiatry: From Biomarkers to Personalized Therapies-A Narrative Review.International journal of molecular sciences · 2025Review
- Towards Enhancing Drug Development Methodology to Treat Cognitive Impairment Associated With Schizophrenia and Other Neuropsychiatric Conditions: Insights From 2 Decades of Clinical Trials.Schizophrenia bulletin · 2025Review
- Service user perspectives and experiences of their diagnosis of psychotic major depression: A qualitative study.PloS one · 2025Article
- Inflammatory Biomarkers, Cognitive Functioning, and Brain Imaging Abnormalities in Bipolar Disorder: A Systematic Review.Clinical neuropsychiatry · 2024Review
- GABAergic dysfunction in postmortem dorsolateral prefrontal cortex: implications for cognitive deficits in schizophrenia and affective disorders.Frontiers in cellular neuroscience · 2024Review
- Localization and Diagnostic Specificity of Glutamic Acid Decarboxylase Transcript Alterations in the Dorsolateral Prefrontal Cortex in Schizophrenia.Biological psychiatry · 2023Article
- Microglia and cognitive impairment in schizophrenia: translating scientific progress into novel therapeutic interventions.Schizophrenia (Heidelberg, Germany) · 2023Review
- Neuropsychological predictors of vocational rehabilitation outcomes in individuals with major depression: A scoping review.Frontiers in psychiatry · 2022Article
- Basal ganglia shape features differentiate schizoaffective disorder from schizophrenia.Psychiatry research. Neuroimaging · 2021Article
- Genetic loci shared between major depression and intelligence with mixed directions of effect.Nature human behaviour · 2021Article
- Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder.Scientific reports · 2021Article
- Feasibility and tolerability of a cognitive remediation clinical service in first episode coordinated specialty care.Early intervention in psychiatry · 2021Article
- Do sleep disturbances contribute to cognitive impairments in schizophrenia spectrum and bipolar disorders?European archives of psychiatry and clinical neuroscience · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
The past 20 years have been witness to a growing knowledge base of research highlighting the critical importance of cognition in understanding functional status and outcome in schizophrenia. This work has led to an increased emphasis on identifying and evaluating treatments that enhance cognition in schizophrenia, with the hope that this would translate into a better quality of life and improved outcome for patients. At the same time, this research has raised new questions about the specificity of cognitive impairments to schizophrenia and the degree to which similar cognitive impairments may be present in other disorders that can involve psychotic symptoms (eg, schizoaffective disorder, bipolar disorder, and psychotic major depression). This article provides a brief overview of work comparing cognitive function across the nonaffective and affective psychoses and highlights areas of similarity and dissimilarity in the role cognition plays in these disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.